GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 59 filers reported holding GAMIDA CELL LTD in Q2 2022. The put-call ratio across all filers is 3.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25 | -99.8% | 19,417 | +209.9% | 0.00% | – |
| Q3 2022 | $10,000 | -63.0% | 6,266 | -59.5% | 0.00% | -100.0% |
| Q2 2022 | $27,000 | +50.0% | 15,454 | +253.6% | 0.00% | – |
| Q1 2022 | $18,000 | -14.3% | 4,370 | -47.1% | 0.00% | – |
| Q4 2021 | $21,000 | +23.5% | 8,264 | +93.8% | 0.00% | – |
| Q3 2021 | $17,000 | -46.9% | 4,265 | -13.9% | 0.00% | -100.0% |
| Q2 2021 | $32,000 | +28.0% | 4,953 | +64.2% | 0.00% | – |
| Q1 2021 | $25,000 | +733.3% | 3,016 | +710.8% | 0.00% | – |
| Q4 2020 | $3,000 | -92.3% | 372 | -96.1% | 0.00% | – |
| Q3 2020 | $39,000 | +550.0% | 9,440 | +577.2% | 0.00% | – |
| Q4 2019 | $6,000 | +100.0% | 1,394 | +111.5% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 659 | -24.9% | 0.00% | – |
| Q2 2019 | $4,000 | – | 877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187 | $107,000,000 | 1.12% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $307,000 | 0.28% |
| Rock Springs Capital Management LP | 2,175,000 | $3,850,000 | 0.11% |
| Platform Technology Partners | 57,625 | $102,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,197,875 | $2,120,000 | 0.05% |
| Guild Investment Management, Inc. | 18,000 | $28,000 | 0.04% |
| MEITAV INVESTMENT HOUSE LTD | 429,352 | $760,000 | 0.01% |
| 1492 Capital Management LLC | 10,000 | $18,000 | 0.01% |
| ARK Investment Management | 714,534 | $1,558,000 | 0.01% |
| FEDERATED HERMES, INC. | 1,868,896 | $3,308,000 | 0.01% |